GOODMAN COREY S purchased 60.5% of their position (3.18M shares) of ALX ONCOLOGY HOLDINGS INC on the open market
Open‑market purchase worth $5.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/4/2026ACC: 0001278411-26-000002
Director10% OwnerOther
Since Jul 2020
+3.18M
Net shares
Net buyer
$5.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.18M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+3.18M
Price / share
$1.57
Trade value
$5M
% of position
60.5%
2/2/2026
5.27M→8.45M
Total
Net shares
+3.18M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/2/2026 | P · Purchase | +3.18M | $1.57 | $5M | 60.5% | 5.27M | 8.45M |
| Total | +3.18M | $5M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned113.29K
Common Stock
IndirectShares owned3.97M
Common Stock
IndirectShares owned54.08K
Common Stock
IndirectShares owned461.81K
Total
4.60M indirect4.60M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 113.29K | Indirect |
| Common Stock | 3.97M | Indirect |
| Common Stock | 54.08K | Indirect |
| Common Stock | 461.81K | Indirect |
| Total | 4.60M | 4.60M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported